Product
Gemcitabine + Dacarbazine
1 clinical trial
1 indication
Indication
High-risk Soft Tissue SarcomasClinical trial
Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant ChemotherapyStatus: Active (not recruiting), Estimated PCD: 2024-06-30